SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following? -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (1183)12/15/2005 9:05:47 AM
From: rkrw  Read Replies (2) | Respond to of 2240
 
I doubt medx has any intention of selling out. I think medx should be up because their big humab license competitor just disappeared.

abgx was a mess, ceo came in cleaned em up, a few restructurings, egfr data come through and they cashed out. Wish I saw it so clearly with foresight :-)



To: Icebrg who wrote (1183)1/19/2006 8:33:03 AM
From: nigel bates  Respond to of 2240
 
I started reading up the details of the poison pill -
sec.gov
- but I have to confess that my boredon threshhold is just too low.

I would be very upset if someone bought the company for less than, say, $150/share...


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News